Literature DB >> 6861006

Life effects of narcolepsy: relationships to geographic origin (North American, Asian or European) and to other patient and illness variables.

R Broughton, Q Ghanem, Y Hishikawa, Y Sugita, S Nevsimalova, B Roth.   

Abstract

A recent questionnaire survey of the life-effects of narcolepsy in 180 patients, 60 each from North American, Asian and European populations, compared to similarly distributed age and sex matched controls, documented multiple and marked effects on work, education, driving, accidents, recreation, personality, memory and other parameters. The data have now been further analysed according to the patients' geographic (culturo-genetic) origin and to a number of other patient and illness variables. The three different geographic populations showed few significant differences for the some 160 life-effects items in the questionnaire. This strongly indicates that these are an integral part of the disease or of the human reactions to it. Most of the few significant population differences appeared cultural in origin (e.g., concerning driving records, personality changes), although a few may possibly reflect genetic differences (e.g., visual problems). Analysis of the pooled data according to respondees' age, sex, age at illness onset, duration of illness and treatment led again to relatively few significant findings. It is concluded that, in general, once the disease has been diagnosed, all the major life effects are present and remain so. The results strongly support the contention that most life-effects are not related to the diagnostic 'tetrad' symptoms themselves but rather to excessive daytime sleepiness, the symptoms most resistant to ant-narcoleptic treatment.

Entities:  

Mesh:

Year:  1983        PMID: 6861006     DOI: 10.1017/s0317167100044723

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

1.  Narcolepsy with resolution of cataplexy and persisting orexin deficiency.

Authors:  Danielle Wasserman; Claudio L A Bassetti; Ivana Rosenzweig
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

Review 2.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

3.  A patient with coexisting narcolepsy and morbid jealousy showing favourable response to fluoxetine.

Authors:  Y K Wing; S Lee; H F Chiu; C K Ho; C N Chen
Journal:  Postgrad Med J       Date:  1994-01       Impact factor: 2.401

4.  Effects of protriptyline on vigilance and information processing in narcolepsy.

Authors:  G K Henry; R P Hart; J A Kwentus; M J Sicola
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Health-related quality of life among drug-naïve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time.

Authors:  Akiko Ozaki; Yuichi Inoue; Toru Nakajima; Kenichi Hayashida; Makoto Honda; Yoko Komada; Kiyohisa Takahashi
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

Review 6.  Antidepressant drugs for narcolepsy.

Authors:  L Vignatelli; R D'Alessandro; L Candelise
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

7.  Endophilin-A coordinates priming and fusion of neurosecretory vesicles via intersectin.

Authors:  Sébastien Houy; Johanna G Peña Del Castillo; Vicky Steubler; Sindhuja Gowrisankaran; Monika Gelker; Jana Kroll; Paulo S Pinheiro; Dirk Schwitters; Nils Halbsgut; Arndt Pechstein; Jan R T van Weering; Tanja Maritzen; Volker Haucke; Nuno Raimundo; Jakob B Sørensen; Ira Milosevic
Journal:  Nat Commun       Date:  2020-03-09       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.